NCT03820206View on ClinicalTrials.gov

The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women

NACompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

November 15, 2019

Study Completion Date

January 2, 2020

Conditions

Intraoperative Bleeding

Interventions

DRUG

Tranexamic Acid

1 g (10 mL) tranexamic acid stored in a dry container at 15 °C-30 °C) diluted in 20 mL of 5% glucose slowly administered intravenously 15 minutes before skin incision over a 5-minute period.

PROCEDURE

Cesarean section

Lower segement transverse cesarean section

Trial Locations (1)

12151

Kasr Alainy medical school, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT03820206 - The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women | Biotech Hunter | Biotech Hunter